Trends in event rates of first and recurrent, fatal and non-fatal acute myocardial infarction, and 28-day case fatality in the Northern Sweden MONICA area 1985 - 98

Scandinavian Journal of Public Health

Volumn 31, Issue 61_suppl, 2003, Pages 51-59

  Messner, Torbjörn ^a,d   Lundberg, Vivan ^b,d   Boström, Stina ^b   Huhtasaari, Fritz ^c   Wikström, Bo ^b  

^a Kiruna District Hospital   (Sweden)

^b Kalix District Hospital   (Sweden)

^c SUNDERBY HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

acute myocardial infarction; case fatality; fatal; MONICA; non fatal; trend

Indexed keywords

ADULT; ARTICLE; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; MORTALITY; RECURRENT DISEASE; SURVIVAL RATE; SWEDEN;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECURRENCE; SURVIVAL RATE; SWEDEN;

EID: 2442426213     PISSN: 14034948     EISSN: 16511905     Source Type: Journal    
DOI: 10.1080/14034950310001388     Document Type: Article

References (24)

1. Sans S., Kesteloot H., Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. [corrected and republished in Eur Heart J 1997; 18 (12): 1231-48 ]. Eur Heart J 1997; 18: 1231-48.
2. Stallones R. The rise and fall of ischemic heart disease. Sci American 1980; 243: 53-59.
3. Uemura K., Pisa Z. Trends in cardiovascular disease mortality in industrialised countries since 1950. World Health Stat Q 1988; 41: 155-78.
4. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 1988; 41: 105-14.
5. Tunstall-Pedoe H., Kuulasmaa K., Mähönen M., Tolonen H., Ruokokoski E., Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547-57.
6. Kuulasmaa K., Tunstall-Pedoe H., Dobson A., Fortmann S., Sans S., Tolonen H., et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000; 355: 675-87.
7. Tunstall-Pedoe H., Vanuzzo D., Hobbs M., Mahonen M., Cepaitis Z., Kuulasmaa K., et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000; 355: 688-700.
8. Nyström L., Rosén M., Wall S. Why are diabetes, stomach cancer and circulatory diseases more common in Northern Sweden? Scand J Prim Care 1986; 4: 5-12.
9. Asplund K., Huhtasaari F., Wester PO [Results from the WHO MONICA study: Northern Sweden has the highest cardiovascular mortality rate]. Lakartidningen 1988; 85: 3182-3, 3186-7.
10. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583-612.
11. Stegmayr B., Lundberg V., Asplund K. The events registration and survey procedures in the Northern Sweden MONICA Project. Scand J Public Health 2003.
12. Nilsson M., Stegmayr B., Lundberg V. MONICA quality assessments. Scand J Public Health 2003.
13. Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985; 4: 87-90.
14. Swedish Board of Health and Welfare. Causes of death 1998 [available at: http://www.sos.se/fulltext/42/2001-42-1/2001-42-1.pdf ].
15. Lindberg G, Rosén M, editors. [Public health and health care.]. Vällingby: Kartförlaget, Gävle, 2000.
16. Jansson JH, Boman K., Messner T. Trends in blood pressure and lipids in the Northern Sweden MONICA project 1986-1999. Scand J Public Health 2003.
17. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. J Am Coll Cardiol 1988; 12: 3A-13A.
18. Peltonen M., Rosen M., Lundberg V., Asplund K. Social patterning of myocardial infarction and stroke in Sweden: incidence and survival. Am J Epidemiol 2000; 151: 283-92.
19. Lundberg V., Wikstrom B., Boström S., Asplund K. Exploring the higher case fatality in women than in men hospitalized for acute myocardial infarction. Manuscript.
20. Peltonen M., Lundberg V., Huhtasaari F., Asplund K. Marked improvement in survival after acute myocardial infarction in middle-aged men but not in women. The Northern Sweden MONICA study 1985-94. J Intern Med 2000; 247: 579-87.
21. Peltonen M., Asplund K. Age-period-cohort effects on ischaemic heart disease mortality in Sweden from 1969 to 1993, and forecasts up to 2003. Eur Heart J 1997; 18: 1307-12.
22. The CONSENSUS Trial Study Group. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1987; 316: 1429-35.
23. The RALES Investigators. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]). Am J Cardiol 1996; 78: 902-7.
24. Hjalmarson A., Goldstein S., Fagerberg B., Wedel H., Waagstein F., Kjekshus J., et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000; 283: 1295-1302.